Sompo Asset Management’s Pfizer PFE Stock Holding History

Sompo Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$366K	Sell	15,210 -3,590	-19%	-$93.9K	0.06%	154
2026 Q1	$528K	Hold	18,800	–	–	0.1%	129
2025 Q4	$468K	Buy	18,800 +1,390	+8%	+$35.1K	0.08%	143
2025 Q3	$444K	Buy	17,410 +3,300	+23%	+$81.5K	0.08%	149
2025 Q2	$342K	Sell	14,110 -7,400	-34%	-$173K	0.06%	162
2025 Q1	$545K	Hold	21,510	–	–	0.1%	130
2024 Q4	$571K	Hold	21,510	–	–	0.1%	121
2024 Q3	$622K	Sell	21,510 -960	-4%	-$28K	0.1%	118
2024 Q2	$629K	Buy	22,470 +2,950	+15%	+$81.2K	0.11%	116
2024 Q1	$542K	Buy	19,520 +2,160	+12%	+$59.9K	0.09%	141
2023 Q4	$500K	Sell	17,360 -2,640	-13%	-$79.8K	0.09%	146
2023 Q3	$663K	Buy	20,000 +3,390	+20%	+$120K	0.15%	115
2023 Q2	$609K	Buy	16,610 +510	+3%	+$19.9K	0.11%	110
2023 Q1	$657K	Buy	16,100 +2,690	+20%	+$116K	0.14%	107
2022 Q4	$687K	Sell	13,410 -1,630	-11%	-$78.1K	0.16%	111
2022 Q3	$658K	Sell	15,040 -48,600	-76%	-$2.36M	0.17%	105
2022 Q2	$3.34M	Sell	63,640 -21,640	-25%	-$1.1M	0.84%	35
2022 Q1	$4.41M	Sell	85,280 -4,340	-5%	-$225K	0.96%	32
2021 Q4	$5.29M	Buy	89,620 +14,280	+19%	+$708K	1.05%	25
2021 Q3	$3.24M	Sell	75,340 -16,980	-18%	-$752K	0.74%	42
2021 Q2	$3.62M	Buy	92,320 +8,500	+10%	+$331K	0.74%	46
2021 Q1	$3.04M	Sell	83,820 -9,050	-10%	-$321K	0.69%	45
2020 Q4	$3.42M	Sell	92,870 -6,069	-6%	-$223K	0.74%	49
2020 Q3	$3.44M	Sell	98,939 -548	-0.6%	-$19.2K	0.83%	45
2020 Q2	$3.09M	Buy	+99,487	New	+$3.38M	0.78%	46
2018 Q4	–	Sell	-38,355	Closed	-$1.6M	–	95
2018 Q3	$1.6M	Sell	38,355 -160,972	-81%	-$6.2M	0.33%	71
2018 Q2	$6.86M	Sell	199,327 -172,025	-46%	-$5.88M	1.55%	21
2018 Q1	$12.5M	Sell	371,352 -3,083	-0.8%	-$106K	2.03%	12
2017 Q4	$12.9M	Sell	374,435 -8,484	-2%	-$289K	1.88%	17
2017 Q3	$13M	Buy	382,919 +44,373	+13%	+$1.43M	1.98%	11
2017 Q2	$10.8M	Buy	338,546 +45,734	+16%	+$1.44M	1.62%	17
2017 Q1	$9.5M	Buy	292,812 +86,228	+42%	+$2.72M	1.18%	36
2016 Q4	$6.37M	Buy	+206,584	New	+$6.31M	0.83%	55

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Sompo Asset Management's PFE Position: Q2 2026 in Review

Sompo Asset Management reduced its Pfizer (PFE) stake by 19% in Q2 2026, selling an estimated $93.9K and leaving 15,210 shares worth $366K. The position accounts for 0.06% of the portfolio, ranked #154.

Sompo Asset Management first reported a position in PFE in Q4 2016 and has held it in 33 quarters since. The position peaked at $13M in Q3 2017. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Sompo Asset Management held 15,210 shares of Pfizer worth $366K as of Q2 2026.
Sompo Asset Management sold 3,590 Pfizer shares in Q2 2026, an estimated $93.9K.
Pfizer made up 0.06% of Sompo Asset Management's portfolio in Q2 2026, its #154 holding.
Sompo Asset Management first reported a position in Pfizer in Q4 2016 and has held it in 33 quarters since.
Sompo Asset Management's Pfizer position peaked at $13M in Q3 2017.
491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sompo Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.